Back To Press Release

EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources

Eva-announcment-10-gilead-for-web-1.png

EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources (Source: EVA Pharma | 1 month ago)

Image
Eva-announcment-10-gilead-for-website-1.png

EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources (FR) (Source: EVA Pharma | 1 month ago)

Image
Eva-announcment-10-gilead-for-web-ar.png

EVA Pharma Signs a Voluntary Licensing Agreement with Gilead to Increase Access to Lenacapavir in 120 Countries with High Human Immunodeficiency Virus (HIV) Incidence and Limited Resources (AR) (Source: EVA Pharma | 1 month ago)

Image